🇺🇸 FDA
Patent

US 10047401

Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer

granted A61PA61P11/00A61P35/00

Quick answer

US patent 10047401 (Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P11/00, A61P35/00